Abstract
Introduction

19
Head and neck squamous cell carcinoma (HNSCC) originates in the epithelial cells of the 20 mucosal linings of the oral cavity, oropharynx, larynx, or hypopharynx [1] . HNSCC has an 21 incidence of 600,000 cases per year worldwide, with a 40-50% mortality rate [2] . Similar to to treating cancers by surgery, chemotherapy, and radiotherapy, these modalities have not 27 significantly changed the survival rate over the past three decades [5] . Thus, more effective 28 treatments for local and metastatic HNSCC are needed.
29
Ocimum sanctum Linn. or Ocimum tenuiflorum Linn., commonly known as Holy Basil in
30
English or Tulsi in Indian language [6] , is a highly potent medicinal herb that is native 31 throughout the eastern tropical countries including Thailand [7, 8] . O. sanctum is primarily 32 composed of phytochemicals [9] . The fresh leaves and stem contain several flavonoids and 33 phenolic compounds. Phenolic compounds such as apigenin, rosmarinic acid, cirsilineol, 34 cirsimaritin, isothymusin, and isothymonin have been detected in O. sanctum leaf extracts [10] .
35
The phytochemicals in this plant varies depending on different growing, harvesting, extraction, 36 and storage conditions [11] . The leaf extracts of O. sanctum have numerous medicinal effects 37 such as anti-oxidant [12, 13] Carlsbad, CA) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml 
93
Three independent experiments were performed.
94
Invasion assay
95
To evaluate cell invasion, an in vitro assay for cell invasion through Matrigel was 96 performed using a blind-well Boyden chemotaxis chamber (Neuro Probe, Gaithersburg, MD) as 97 previously described [22] . Briefly, the upper surface of 13 μm pore polycarbonate filters (Fisher 
Conditioned medium preparation and zymography
111
HNSCC cells (2x10 6 cells) were cultured in 6-well plates and incubated at 37°C for 24 h.
112
After incubation, the wells were washed with PBS and treated with 0.4 mg/ml EEOS diluted in 113 DMEM containing 0.1% BSA for 48 h. Cells cultured in DMEM containing 0.1% BSA were 114 used as control. Conditioned medium (CM) was collected and centrifuged at 1,000 g and 4°C for 115 10 min. The CM was stored at -80°C until used. Total protein in the CM was estimated using the 116 Pierce TM BCA protein assay kit (Thermo Fisher Scientific, Waltham, MA).
117
MMP-2 and MMP-9 activity in the CM were measured using gelatin zymography as 118 previously described [23] . Briefly, gelatin (bloom 300, Sigma) was added to a 10% acrylamide 
HPLC-ESI-TOF-MS analysis of EEOS
130
The O. sanctum extract was chemically analyzed using high-performance liquid an HPLC system (UltiMate® 3000 system, Thermo Fisher Scientific, Sunnyvale, CA). Caffeic 134 acid, rosmarinic acid, and apigenin standards were prepared (10, 50, 100, 150, 200, and 250 135 µg/ml). HPLC was performed using a reverse phase column (Symmetry C18 analysis column, 2.1 136 mm x 150 mm, and 5 µm particle size). A gradient elution was performed with a mobile phase of 
Statistical analysis
148
The results are presented as means and standard error of the mean (SEM). Statistical 149 analysis was performed using one-way ANOVA followed by the Tukey's multiple comparisons 
Results
153
Cytotoxic assessment of EEOS on the HNSCC cell lines
154
The cytotoxic effect of EEOS on the HNSCC cell lines was evaluated using an MTT 155 assay (Fig 1) . EEOS (0.8 mg/ml) significantly decreased the HN30, HN31, HN4, and HN12 cell 156 viability to approximately 40%, 53%, 52%, and 40%, respectively, of that of their controls (P < 157 0.05). Whereas, 0.05, 0.1, 0.2, and 0.4 mg/ml EEOS were non-toxic to the cell lines. Therefore, 158 the HNSCC cell lines were treated with 0.4 mg/ml EEOS and their invasion and MMP-2 and-9 159 activity were evaluated. 161 We found that HN30 and HN31 cell line invasion was not significantly inhibited by the 162 non-toxic dose of EEOS (0.4 mg/ml) compared with control (P > 0.05) (Figs 2A and B) . In 
160
EEOS decreased metastatic HNSCC invasion
165
EEOS reduced MMP-2 and -9 activity of HNSCC cell lines
166
MMP-2 and MMP-9 activity was detected and quantified as gelatinolytic bands and 167 arbitrary number of intensity, respectively. We found that 0.4 mg/ml EEOS treatment did not 168 alter MMP-2 and MMP-9 activity of HN30 and HN31 cells (Fig 3A) . However, MMP-2 and 169 MMP-9 activity of HN4 and HN12 cells were downregulated when treated with EEOS (Fig 3B) . 
177
HPLC analysis of EEOS
178
The HPLC retention times of caffeic acid, rosmarinic acid, and apigenin standards were 179 determined (Fig 4A) . The EEOS chromatograms demonstrated peaks 1, 2, and 3 with retention 180 times that corresponded to those of the caffeic acid, rosmarinic acid, and apigenin standards, 181 respectively ( Fig 4B) .
182
Structural identification of the compounds in EEOS
183
HPLC-ESI-MS parameters were optimized and used to profile the EEOS. The selected 3 184 compounds in EEOS were putatively identified by comparison to the database (Table 1) .
185
Moreover, structures of the putative compounds were drawn by comparison to the known 186 structure of standard compounds. The result revealed that compounds 1, 2, and 3 were caffeic 187 acid, rosmarinic acid, and apigenin, respectively ( Figs 5A and A) . Quantification of the EEOS 188 caffeic acid, rosmarinic acid, and apigenin indicated that rosmarinic acid was the major phenolic 189 component (Fig 5C) . We evaluated the effect of EEOS on HNSCC invasion and MMP activity. We found that EEOS 210 decreased HN4 and HN12 cell invasion by attenuating MMP-2 and MMP-9 activity. In contrast, Quantification of the compounds in EEOS (C).
